Document is current
Any future updates will be listed below
-
Authors
Heeman, Fiona https://orcid.org/0000-0001-7769-8329
Yaqub, Maqsood https://orcid.org/0000-0003-2122-740X
Hendriks, Janine
van Berckel, Bart N. M. https://orcid.org/0000-0003-1811-4383
Collij, Lyduine E.
Gray, Katherine R.
Manber, Richard
Wolz, Robin
Garibotto, Valentina https://orcid.org/0000-0003-2422-698X
Wimberley, Catriona
Ritchie, Craig https://orcid.org/0000-0002-6202-6906
Barkhof, Frederik https://orcid.org/0000-0003-3543-3706
Gispert, Juan Domingo https://orcid.org/0000-0002-6155-0642
Vállez García, David https://orcid.org/0000-0003-3308-3167
Lopes Alves, Isadora https://orcid.org/0000-0002-1230-8139
Lammertsma, Adriaan A. https://orcid.org/0000-0003-1237-2891
,
-
Funding
Funding for this research was provided by:
Ministerio de Ciencia, Innovación y Universidades (RYC-2013-13054)
Innovative Medicines Initiative (115372, 115952)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320030_169876, 320030_185028, IZSEZ0_188355)
Velux Stiftung (1123)
- License Information
-
More Information
Article History
Received: 14 January 2022
Accepted: 25 April 2022
First Online: 12 May 2022
Declarations
:
: Study protocols were approved by all local Medical Ethics Review Committees. Before participating in the study, all participants provided written informed consent in accordance with the Declaration of Helsinki.
: Before participating in the study, all participants provided written informed consent in accordance with the Declaration of Helsinki.
: VG received financial support for research and/or speaker fees through her institution from Siemens Healthineers, GE Healthcare, Life Molecular Imaging, Cerveau Technologies, Roche, Merck.
